HDAC2 deficiency and histone acetylation

Nature Genetics

Volumn 40, Issue 7, 2008, Pages 812-813

  Ree, Anne Hansen ^a,b   Folkvord, Sigurd ^a,c   Flatmark, Kjersti ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 2; HISTONE H3; HISTONE H4; TRICHOSTATIN A;

ACETYLATION; CANCER CELL; COLORECTAL CARCINOMA; CYTOTOXICITY; DNA FINGERPRINTING; ENZYME INHIBITION; GENETIC VARIABILITY; HUMAN; IONIZING RADIATION; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIZATION;

ACETYLATION; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HISTONE DEACETYLASES; HISTONES; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; REPRESSOR PROTEINS;

EID: 46249110936     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0708-812     Document Type: Letter

References (6)

1. Cerna, D. et al. Curr. Top. Dev. Biol. 73, 173-203 (2006).
2. Nome, R.V. et al. Mol. Cancer Ther. 4, 1231-1238 (2005).
3. Flatmark, K. et al. Radiat. Oncol. 1, 25 (2006).
4. Ropero, S. et al. Nat. Genet. 38, 566-569 (2006).
5. Kelly, W.K. & Marks, P.A. Nat. Clin. Pract. Oncol. 2, 150-157 (2005).
6. Bolden, J.E. et al. Nat. Rev. Drug Discov. 5, 769-784 (2006).